An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
Let's dive in.
A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this strategy may not be effective for everyone.
The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...
By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...
Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. But injectable medications aren’t right for everyone. That’s where a new wave of oral GLP-1 ...
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...
Add Yahoo as a preferred source to see more of our stories on Google. CEO Sam Tejada, and CMO Dr. Christopher Davis of 'Liquivida' stopped by the KTLA Weekend Morning News to explain the difference ...
"Physician here. Yes, GLP-1 medications are life-saving and life-changing meds, absolutely. The issue is that OP's partner ...
Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities.
Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results